Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Increased Th17 response to myelin peptides in pediatric MS.
Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel.
Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.
Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis.
Complex assessment in progressive multiple sclerosis: a case report.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Mitochondrial dysfunction in central nervous system white matter disorders.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.
Multiple Sclerosis: Risk Factors and Their Interactions.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.

Pages